Wang KQ, Xie WF. Reply to "Rifaximin and the DCA-serotonin axis in cirrhotic portal hypertension: how much of the benefit is bile-acid specific?". J Hepatol 2026 Aug 21:S0168-8278(26)02858-8. doi: 10.1016/j.jhep.2026.
PMID: 42628656